PRKACA and hepatocellular carcinoma: Twenty unique HLA class I ligands derived from the DNAJB1-PRKACA fusion protein were identified in the three HCC cell lines with two ligands spanning the fusion region (Fig. 3d, Supplementary Fig. S3b).